Lapsed Jul 24, 2020 on the fee record · High confidence
20-year base term ends Nov 27, 2026
Second maintenance fee unpaid; grace period ended.
Held by GlaxoSmithKline Biologicals S.A.
Filed Jan 26, 2009 as application 12/085,413 · Granted Jul 24, 2012
Base term, 20 years from filing, plus 849 days of patent term adjustment (USPTO delay)
Today
Lapsed Jul 24, 2020
2006
2029
Clock starts
Nov 27, 2006
Nov 27, 2006
No longer in force
Jul 24, 2020
Jul 24, 2020
Granted
Jul 24, 2012
Jul 24, 2012
Term would have run to
Mar 25, 2029
Mar 25, 2029
base term
patent term adjustment
after the term ends
fee events
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
849
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
Its term would have run to Mar 25, 2029: its 20-year base term plus 849 days of term adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 27, 2006, when application PCT/IB2006/003876, the earliest non-provisional in its chain, was filed (this one was filed Jan 26, 2009) | Nov 27, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +849 days, USPTO patent term adjustment record | Mar 25, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | lapsed Jul 24, 2020 | High confidence |
| Computed term end | The steps above, in order | Jul 24, 2020 | High confidence |
Partial family
| Application PCT/IB2006/003876 | PCT application no patent term | no patent term |
| US 8,226,960 | this patent Jul 2020 | Jul 2020 |
| US 8,398,999 | Lapsed on the fee record Mar 2021 | Mar 2021 |
| US 9,156,894 | In force Nov 2026 | Nov 2026 |
Partial: 1 of the 4 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 7, 2008 Reel 21806, frame 474 | Novartis Vaccines and Diagnostics SRL | Novartis AG | Assignment of Assignor's Interest |
| Jan 27, 2011 Reel 25709, frame 18 | Novartis Vaccines and Diagnostics SRL | Novartis AG | Assignment of Assignor's Interest |
| Jul 14, 2016 Reel 39348, frame 942 | Novartis AG | GlaxoSmithKline Biologicals S.A. | Assignment of Assignor's Interest |
| Oct 20, 2016 Reel 40077, frame 814 | Novartis Vaccines and Diagnostics SRL | GlaxoSmithKline Biologicals S.A. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Note
The 849 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
25
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.